Advertisement

PharmacoEconomics & Outcomes News

, Volume 818, Issue 1, pp 19–19 | Cite as

Natriuretic-guided HF therapy: no QOL effect, higher cost

Clinical study
  • 7 Downloads

Reference

  1. Mark DB, et al. Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. Journal of the American College of Cardiology 72: 2551-2562, No. 21, 27 Nov 2018. Available from: URL: http://doi.org/10.1016/j.jacc.2018.08.2184

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations